CALLUNA PHARMA US, INC.
Keywords
researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors
Organization
- CEO
- Years since formation
- 0 years
- since Aug 7, 2025
- Type
- Norwegian division of foreign business enterprise
- VAT registered
- No
- Number of employees
- 0
Last update: Aug 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
| Information about the Company in the Home Country | - |
Last update: Aug 7, 2025
Ownership
No available data
Financials
in NOK
No available data
Classification
Type of organization
Norwegian division of foreign business enterprise
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology